About Ross Levine
Form D filings for Ajax Therapeutics from 2019 to 2024 list Ross Levine as director.
Ross Levine first appears on SEC filings in 2019.
Experience
This experience comes from SEC filings. The years are when the filings name Ross Levine in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Ross Levine works with at each company, as listed on that company's latest Form D.
Ajax Therapeutics, Inc. · Form D, May 13, 2024